Loading...
Reimbursement challenges with cancer immunotherapeutics
Today the task of cancer vaccine developers is not only to excel in cancer immunology and art of conducting immunotherapy trials but also in the analysis and forecasting the cost-effectiveness of the final product. This article reviews methodology used by EU health-technology bodies in the appraisal...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Landes Bioscience
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3579918/ https://ncbi.nlm.nih.gov/pubmed/22894969 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.20550 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|